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Summary 
Nine 'carcinoids' of the breast (argyrophilic carcinomas) were examined for the presence of estrogen receptor 
(ER), progesterone r ceptor (PR), and androgen receptor (AR), using immunohistochemistry. Thetumours 
were selected on the basis of their histo-morphological appearance and positive Grimelius stain. All cases 
were immunoreactive for neuron-specific enolase (NSE). In one case the tumour cells were intensely chro- 
mogranin A positive. All cases were ER positive, while 5 cases expressed AR and 5 cases PR. Immunostaining 
for ER and simultaneous demonstration of argyrophilia or chromogranin A expression i  chromogranin A 
positive argyrophilic carcinoid tumour of the breast provided further evidence that neuroendocrine c lls in 
breast tumours express ex steroid receptors. The similarity in sex steroid receptor expression pattern in 
'carcinoids' of the breast and the more common categories of breast cancer suggests an identical respon- 
siveness to endocrine therapy. 
Introduction 
The term 'carcinoid tumour of the breast' is applied 
to tumours with the classical organoid histomorph- 
ological appearance of a 'carcinoid' [1]. These tu- 
mours almost entirely consist of argyrophilic cells. 
However, there is a lot of confusion surrounding 
these so-called carcinoid tumours of the breast. 
Features of neuroendocrine differentiation like ar- 
gyrophilia may also be present in a variable propor- 
tion of tumour cells in conventional infiltrating duc- 
tal and lobular carcinomas [2-7]. Besides this, only 
few argyrophilic breast cancers express chromogra- 
nin A [8] and there is little evidence of ectopic hor- 
mone production [1, 9]. Now, the term 'carcinoma of 
the breast with neuroendocrine differentiation' is 
preferred for mammary tumours expressing neu- 
ron-specific enolase (NSE) and/or chromogranin 
irrespective of the histopathological growth pat- 
tern. 
The responsiveness of the majority of ductal and 
lobular carcinomas to endocrine therapy is reflect- 
ed by their f equent expression of ER and PR. Simi- 
larly, a large proportion of breast carcinomas con- 
tains AR [10,11]. Except for a few biochemical stud- 
ies on ER protein [4,12,13], no data are available on 
sex steroid receptor expression i (argyrophilic) tu- 
rnouts of the breast with neuroendocrine differen- 
tiation and the histological growth pattern of 'carci- 
noid'. The aim of this study was to investigate the 
presence of ER, PR, and AR in the argyrophilic 
cells of these 'carcinoids' of the breast with a set of 
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Figure 1. Case 7. Low power micrograph s owing the typical histomorphological pattern of a carcinoid tumour. Tumour cells are arranged 
in larger solid fields. Hematoxylin-eosin. Objective 5 x.
specific monoclonal antibodies using immunohisto- 
chemistry. If the distribution of these sex steroid re- 
ceptors among 'carcinoids' of the breast is similar to 
that found in conventional breast carcinomas, they 
could be regarded as well-differentiated breast can- 
cers with a similar responsiveness to endocrine 
therapy. 
idase complex (ABC) method [141. An additional 
case of a typical infiltrating ductal carcinoma with 
focal expression of chromogranin A was included in 
the study. Immunoreactivity with a rabbit antibody 
(diluted 1:800 in PBS) to neuron-specific enolase 
(Dakopatts, Copenhagen, Denmark) was also dem- 
onstrated with a routine ABC method. 
Materials and methods lrnmunostaining for ER, PR, and AR 
Paraffin-embedded specimens of 'carcinoid' tu- 
rnouts of the adult female breast fixed in phosphate 
buffered formaldehyde 4% (pH 7.0) were cut in 
5 gm thick sections. Eight cases were selected from 
the archives of the Dept. of Pathology of the 
Netherlands Cancer Institute in Amsterdam, and 
one additional case from the Dept. of Pathology of 
the University Hospital Dijkzigt in Rotterdam. All 
patients are still alive, two to five years after diag- 
nosis. Expression of chromogranin A was detected 
with monoclonal antibody LK2H10 (Euro-diagnos- 
tica, Apeldoorn, The Netherlands), diluted 1:30 in 
phosphate buffered saline (PBS) solution (pH 7.4) 
followed by a routine streptavidin-biotin-perox- 
For detection of ER, PR, and AR, an antigen re- 
trieval method was applied as described previously 
[15]. Briefly, the sections were dried at 60 ° C for 20 
minutes, deparaffinized in xylene for 7 minutes, and 
immersed in 100% alcohol. Subsequently, endoge- 
nous peroxidase activity was blocked by treatment 
with 0.3% hydrogen peroxide in methanol for 20 
minutes, and the sections were rinsed in distilled 
water. The slides were placed in a plastic box filled 
with 0.01 M citrate buffer pH 6.0, and processed in 
the microwave oven 3 times for 5 minutes at 700 W. 
After cooling down to room-temperature, theslides 
were rinsed in PBS and pre-incubated for 15 min- 
utes with normal goat serum (DAKO Glostrup, 
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Figure 2. Argyrophilic granules in the cytoplasm (case 7). Most cells are positive. Grimelius silver stain. Objective 40 x. 
Denmark), diluted 1:10 in PBS. Next, the sections 
were incubated overnight at 4 ° C with a monoclonal 
antibody against ER, PR (Immunotech, S.A.) [16], 
and monoclonal antibody F39.4 (Biogenex, CA, 
USA) directed against AR [17]. The specificity of 
F39.4 on paraffin sections for AR has been de- 
scribed earlier [18-20]. A standard ABC technique 
(DAKO Glostrup, Denmark) was used for visual- 
ization with 3,3'-diaminobenzidintetrahydrochlo- 
ride (Fluka, Basel, Switzerland) as chromogen and 
H202 as substrate. As a positive control, breast car- 
cinoma sections known to be positive for ER and 
PR were used. Prostatic tissue was used as a positive 
control for AR. As negative controls the primary 
antibodies pecific for ER, PR, AR, and chromo- 
granin A or neuron-specific enolase were substitut- 
ed by PBS. 
Grimelius ilver staining 
All cases were selected on the basis of their positive 
reaction with the Grimelius silver-stain essentially 
as described by Grimelius [21]. 
Simultaneous detection of ER and argyrophilic 
granules 
Immunostaining for ER was followed by the Gri- 
melius stain. To intensify the argyrophilic staining 
reaction, the procedure was repeated by perform- 
ing the cycle of incubations with Grimelius A and B 
solution up to 4 times five minutes. For visualization 
of ER by the bound ABC complex, the sections 
were immersed in freshly prepared 3-amino-9-eth- 
yl-carbazole (AEC) solution yielding a red precip- 
itate. After the Grimelius staining reaction the sil- 
ver grain precipitate was amplified with an 0.1% (v/ 
v) sodium acetate solution containing 0.02 % AuC13. 
This solution was kept on the slides for two minutes. 
Next, the non-specific metal-complex was removed 
by rinsing with 5 % sodium-thiosulfate. The incuba- 
tion with AuC13 is probably based on a redox reac- 
tion. By this procedure the precipitated silver 
grains, linked to protein in neuroendocrine c lls, as- 
sume a darker brown violet colour. In this way 
background staining was minimized without influ- 
encing the intensity of the AEC precipitate. As pos- 
itive controls pancreas and lung tissue were used. 
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Figure 3. "Carcinoid' tumour of the breast (case 7) immunostained for chromogranin A. Dispersed cells show immunoreactivity. Ob-
jective 100 x. 
Double-staining with chrornogranin A and ER Results 
In two cases of'carcinoid' of the breast, asequential 
immunostaining for ER and chromogranin A was 
performed. We first applied the antibody to chro- 
mogranin A in a 1:30 dilution in PBS for 30 minutes, 
using alkaline phosphatase conjugated rabbit anti- 
mouse immunoglobulin (DAKO, Denmark) as sec- 
ondary antibody. The sections were thoroughly 
washed and subsequently the procedure for ER de- 
tection was followed. 
Quantification 
The percentage ofER, PR, and AR positive tumour 
nuclei was calculated by counting the number of 
positive cells on a total of 300 cells in three different 
tumour areas. Tumours with a staining percentage 
less than 10% were regarded as negative. We desig- 
nate our tumours as carcinoids, instead of argyro- 
philic tumours, to stress that they possess aclassical 
endocrine appearance and are not mucinous tu- 
mours (Figure 1). 
In the nine 'carcinoids' of the breast we observed 
three staining patterns after the Grimelius reaction. 
Five tumours had a faint, rather homogenous gran- 
ular staining. In three tumours we found scattered 
intensely positive c lls in association with the faint, 
more diffuse, distribution pattern. One tumour al- 
most entirely consisted of cells with a dense gran- 
ular staining (Figure 2). In the latter tumour a posi- 
tive chromogranin A staining was observed (Figure 
3), while the remaining cases lacked immunoreac- 
tivity for this marker. In all nine cases a homoge- 
nous expression of neuron-specific enolase was ob- 
served, consistent with their putative neuro-endo- 
crine differentiation. 
All nine cases were ER positive (Figure 4), and in 
5 cases a large proportion of PR positive tumour 
cells was present. The percentage ofAR positive tu- 
mour cells within a tumour was on average lower 
than that of ER and PR. Three tumours expressed 
ER as the only receptor and 4 showed ER and PR as 
well as AR. In some tumours cytoplasmic staining 
for PR and AR was noted. No stromal sex steroid 
receptor expression was noted. The distribution of 
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ER, PR, and AR expression among the 9 'carcinoid' 
cases is given in Table 1. 
Double-staining performed on the 9 'carcinoid' 
tumours of the breast revealed a coexpression of 
both argyrophilic granules in the cell's cytoplasm 
and ER in the cell's nucleus. Similarly, in the one 
case with a positive chromogranin A staining, tu- 
mour cells expressing ER were also chromogranin 
A positive. The infiltrating ductal carcinoma with 
scattered neuroendocrine tumour cells showed oc- 
casional coexpression of chromogranin A and ER. 
However, the majority of the chromogranin A posi- 
tive cells were ER negative. 
Discuss ion  
This paper demonstrates that all nine examined 
'carcinoid' tumours of the breast express ER. Simi- 
larly, Chabon et al. [12] and others [4,13] found very 
high levels of ER in breast carcinomas with argy- 
rophilic turnout cells, using a biochemical ligand 
binding assay. This coincides with the high propor- 
tion of ER positive cases in well-differentiated infil- 
trating ductal carcinomas [22]. The lower number 
of PR and particularly AR positive tumour cells in 
argyrophilic arcinomas i also in line with the PR 
and AR expression i  infiltrating ductal carcinomas 
[10]. 
A controversial issue is whether (argyrophilic) 
'carcinoids' of the breast should indeed be consid- 
ered true neuroendocrine tumours imilar to those 
encountered in other organs (e.g. those of the gas- 
trointestinal tract). According to several authors, 
argyrophilia in breast umours is not necessarily re- 
lated to the neuroendocrine nature of a breast u- 
mour. These authors related argyrophilia to the 
presence of milk proteins such as lactalbumin [23- 
25]. However, these authors used the Sevier-Mun- 
ger method for demonstration, while Cross [26], 
Toyoshima [7], and Fetissof et al. [2], did not find 
any evidence of argyrophilia in lactating breast is- 
sue using the Grimelius procedure. They consid- 
ered the possibility of lactalbumin as a cause of ar- 
gyrophilia less likely. In an ultrastructural study 
Ferguson and Anderson [27], in accordance with 
Clayton [23], attributed the presence of dense core 
granules (DCG) to prelactational differentiation 
rather than neuroendocrine differentiation. The 
presence of dense core granules in normal non- 
pathological breast tissue confirms this finding [2, 
4-6, 27]. Another argument against he view of 'car- 
cinoids' being a distinct ype of breast umour, is the 
finding of a high incidence (50%) argyrophilia-pos- 
itive 'normal breast cancers' by Taxy et al. [4]. Un- 
like this, Partanen and Azzopardi et al. [5, 6] only 
found an incidence of resp. 3,3% and 4.5%. The fre- 
quently observed absence of chromogranin A (a 
constituent of neuroendocrine granules) expres- 
sion in 'carcinoids' of the breast and the lack of con- 
Table 1. Sex steroid receptor expression and Grimelius taining pattern in carcinoid tumours of the breast. Tumours with a staining 
percentage less than 10% were regarded as negative 
Cases Grimelius ER (%) AR (%) PR (%) Age Stage 
Diffuse Focal 
1 + - 53 21 8 60 TIN0 
2 +++ - 11 2 10 68 T1N0 
3 ++ - 63 33 52 82 T2N0 
4 +/- - 51 0 8 89 T2N1 
5 + ++++ 54 0 7 78 T2N0 
6 ++ ++++ 33 0 6 83 T2N1 
7 ~ ++++ - 70 14 49 71 T2N1 
8 +++ - 63 28 42 75 T1N0 
9 + +++ 26 19 13 70 T2N0 
On average two chromogranin A positive cells, less than 1%, per tumour field (10 x objective) were seen. 
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Figure 4. 'Carcinoid' tumour of the breast immunostained for ER. Most nuclei are positive for estrogen receptor (case 7). Objectiv  20 x. 
sistent evidence that neuroendocrine c lls produce 
ectopic hormones [2, 4, 8], are additional arguments 
for the view that at least a proportion of the 'carci- 
noids' of the breast are not true neuroendocrine tu- 
mours. 
Currently, the presence of scattered (chromogra- 
nin A positive) neuroendocrine tumour cells within 
an infiltrating ductal carcinoma is attributed to a 
multidirectional differentiation of tumour cells dur- 
ing the neoplastic process [2, 28, 29]. In one case, an 
ER positive infiltrating ductal carcinoma with focal 
neuroendocrine differentiation, we showed the ex- 
pression of ER in only a few chromogranin A posi- 
tive cells; the bulk of chromogranin A positive cells 
was ER negative. This observation is comparable to 
the lack of AR in tumour cells with neuroendocrine 
differentiation i human prostatic arcinomas [30, 
31]. 
Whatever hypothesis on the nature of carcinoids 
of the breast holds true, one of our cases represents 
a true neuroendocrine tumour in that all tumour 
cells are intensely argyrophylic associated with a 
strong chromogranin A expression in a small 
amount of tumour cells (Figures 2 and 4). The high 
expression of ER (Figure 3) and PR in this case 
clearly shows that neuroendocrine 'carcinoid' tu- 
mour of the breast may express ex steroid recep- 
tors like conventional breast carcinomas. Double 
staining confirmed the ER expression in chromo- 
granin A reactive tumour cells in this case. 
Our results with regard to sex steroid receptor ex- 
pression indicate that 'carcinoids' of the breast have 
more in common with conventional breast cancer. 
As to the prognosis, this small series of 'carcinoids' 
of the breast seems to display a favourable biolog- 
ical behaviour, since all patients are alive two to five 
years after diagnosis. The low tumour stage simi- 
larly reflects a favourable prognosis. This is consis- 
tent with the view that 'carcinoids' of the breast 
should indeed be considered as well-differentiated 
carcinomas. 
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